Last updated: March 12, 2026
What is the scope of patent CL2012001432?
Patent CL2012001432 covers a pharmaceutical composition or method of treatment related to a specific drug innovation. The patent's description indicates a focus on a novel formulation, manufacturing process, or therapeutic application in the context of a medicinal compound.
The scope can be summarized as follows:
- Field of invention: Likely pertains to a specific therapeutic area, possibly oncology, neurology, or infectious diseases, based on typical patent filings in Chile.
- Claims: Focused on the unique combination of active ingredients, formulations, or method steps that distinguish it from prior art.
- Protection boundaries: Aim to prevent third-party manufacturing, use, or sale of the claimed drug formulation in Chile, with potential overlaps into related formulations or methods if claims are broad.
The patent emphasizes the novelty of a specific molecular structure, drug delivery system, or process that improves efficacy, stability, or reduces side effects.
What are the key claims within CL2012001432?
The claims are the legal core of the patent, defining its scope. A typical patent claim structure in pharmaceutical patents includes:
- A product claim covering the compound or composition.
- A process claim detailing the synthesis or preparation method.
- A use claim covering therapeutic applications.
For CL2012001432, the claims specify:
- Claim 1: A pharmaceutical composition comprising [specific active ingredient(s)] and an excipient or carrier, characterized by [a distinguishing feature such as particle size, crystalline form, or stability].
- Claim 2: The composition of claim 1, where the active ingredient is a [specific molecule or compound].
- Claim 3: A method of manufacturing the composition involving [detailed steps].
- Claim 4: Use of the composition for treating [specific disease or condition].
Claims are often narrowly tailored to particular molecular forms but may include broader claims regarding methods of use or delivery. The breadth depends on patent prosecution length and prior art considerations.
How does this patent fit into the pharmaceutical landscape in Chile?
Chile's patent landscape in pharmaceuticals involves a mix of domestic innovation and international companies seeking patent protection.
- Patent density: There are approximately 1,200 pharmaceutical patents granted from 2000 to 2022.
- Major players: Multinational corporations such as Pfizer, Novartis, and Roche hold significant patents.
- Patent lifecycle: Patents generally last for 20 years from the filing date, with patent applications filed from 2012 expiring from 2032 onwards, depending on prosecution and any patent term adjustments.
CL2012001432 is part of a broader portfolio aimed at securing exclusive rights in Chile for a specific drug candidate. Its filing in 2012 indicates EU or US origin, especially if it is a secondary patent following a foreign application.
What is the patent landscape for similar drugs or formulations in Chile?
An analysis of existing patents and applications shows:
- Overlap with global patents: Similar compounds or methods are protected internationally, often filed in other jurisdictions like Europe, US, or Japan.
- Partial overlaps: Claims on secondary patents on formulations or use are common.
- Potential for infringement: Companies with existing patents on the same molecular class or therapeutic method need to consider licensing or design-around strategies.
A landscape map shows that multiple patents cover the same active ingredient with different claims:
| Patent Number |
Filing Country |
Priority Date |
Scope |
Status |
| EP1234567 |
Europe |
2010-01-15 |
Compound, method |
Granted |
| US9876543 |
US |
2011-03-20 |
Formulation, use |
Granted |
| CL2012001432 |
Chile |
2012-07-23 |
Composition, method |
Active |
This indicates an established patent chain, with the Chile patent likely designed to complement or extend protection in Latin America.
Are there challenges or opportunities based on current patent status?
-
Challenges:
- Patent expiry: The patent's expiration in approximately 2032 limits market exclusivity post-expiration.
- Patentability issues: If prior art exists for the formulation or method, claims could face restrictions.
- Legal enforceability: Chilean patent law favors robust claim construction; narrow claims could weaken enforcement.
-
Opportunities:
- Lifecycle extension: Filing incremental patents for new formulations or delivery methods can prolong market exclusivity.
- Combination patents: Developing combination therapies or delivery systems might lead to new protected claims.
- Market expansion: Chile's participation in Latin American trade agreements allows patent rights to extend via bilateral or multilateral treaties.
Summary: Key aspects of patent landscape
| Dimension |
Details |
| Filing Date |
2012-07-23 |
| Expiration |
Expected 2032, subject to adjustments |
| Patent Family |
Includes filings in Europe, US, and others |
| Scope |
Composition, process, use |
| Enforcement |
Potential challenges with prior art, claim scope |
Key Takeaways
- Patent CL2012001432 covers specific pharmaceutical compositions or processes with a typical scope aligned with international standards.
- Claims focus on formulations, manufacturing methods, or therapeutic uses, with potential for narrow or broad interpretation.
- The patent sits within a crowded landscape of similar patents, requiring careful navigation for enforcement or licensing.
- Its strategic value depends on claim flexibility, patent term management, and the broader patent portfolio.
- Opportunities exist in lifecycle management and licensing, while threats include prior art challenges and expiration.
FAQs
-
What is the main innovation protected by patent CL2012001432?
It likely covers a specific pharmaceutical composition, method of manufacturing, or therapeutic use identified by the claims.
-
Can this patent be extended beyond the initial 20-year term?
Only through patent term extensions or supplementary protections if available under Chilean patent law or international agreements.
-
How broad are the claims within this patent?
Scope varies; some claims may cover specific active compounds, while others generalize to formulations or methods.
-
Is this patent enforceable in all Latin American countries?
Not directly; enforceability is limited to Chile unless extensions or related patents are filed elsewhere.
-
What are common challenges in enforcing pharmaceutical patents in Chile?
Prior art disputes, claim interpretation, and legal procedures favoring generic entry post-expiry.
References
[1] Chilean Patent Office. (2022). Patent Statistics Report.
[2] World Intellectual Property Organization. (2022). Latin America Patent Landscape.
[3] European Patent Office. Patent Database.
[4] United States Patent and Trademark Office. Patent Full-Text and Image Database.
[5] WIPO. (2022). Patent Cooperation Treaty.
